Results from randomized controlled clinical trials investigating populations covering the spectrum from ocular hypertension to advanced glaucoma provide clear evidence that for most patients, glaucoma is an IOP-sensitive optic neuropathy for which lowering IOP is effective in slowing or arresting progression.
Ophthalmologists should not order routine genetic tests for patients with common disorders like age-related macular degeneration until there are specific therapeutic interventions available to treat the disease based on the genetic information.
The acceleration of research focused on dry eye over the past several decades has led to an increase in knowledge regarding the pathophysiology of the disease.
Dry eye comes in a variety of guises and, once diagnosed, may require various therapeutic options.
The world of glaucoma management in 2012 is feeling the impact of not only a variety of challenges, but also new opportunities.
Many ophthalmologists may be dropping the ball when treating moderate dry eye, which could result in progression to more severe stages of disease.
Having the ARVO meeting in any of various locations enables the group to accommodate more program options and have a variety of hotel options nearby.
FDA investigators say counterfeit vials of Roche/Genentech's bevacizumab that have turned up in U.S. medical practices for the second time in 2 months have no active ingredient.
Tear osmolarity is well correlated to visual function, and may also be a key marker of dry eye disease
Ophthalmologists expressed a little more optimism than primary-care physicians, when asked to evaluate the financial state of their practices in a national survey conducted in 2011.
The golden rule, a maxim the author learned in kindergarten, remains crucial to his practice of medicine today.
It is vital to identify and prevent dry eye and blepharitis pre-surgery because these conditions can affect IOL calculations and more.
The tear layer approach is effective in the diagnosis and treatment of dry eye syndrome.
Though advances have been made in achieving better functional vision in some patients with ocular injuries, the overall rates of improvements in visual acuity have remained static for three decades.
Marguerite McDonald, MD, an ophthalmologist with Ophthalmic Consultants of Long Island, has been named the recipient of the Ophthalmic Women Leaders (OWL) 2012 Visionary Woman Award.
MacuCLEAR Inc. is beginning phase III studies for its lead compound, MC-1101, for the treatment of early-stage (dry) age-related macular degeneration (AMD).
OptiMedica Corp. has announced that its proprietary platform that combines a femtosecond laser, integrated three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern-scanning technology (Catalys Precision Laser System) has been granted CE mark approval for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.
A diet rich in zinc, vitamins C and E, lutein, zeaxanthin, and long-chain omega-3 fatty acids promotes health in the aging eye, according to a multidisciplinary roundtable of experts convened by the Ocular Nutrition Society and representing the fields of ophthalmology, optometry, diet and nutrition, and primary care.
Patients taking oral fluoroquinolones have a higher risk of developing a retinal detachment compared with those who are not taking them, according to a study recently published in the Journal of the American Medical Association.
Results of motor vehicles agency-administered vision tests do not necessarily reflect fitness to drive, according to a study published in Investigative Ophthalmology & Visual Science.
EyeCare America is offering free or no out-of-pocket cost eye exams to qualifying individuals in underserved populations during April, National Minority Health Month.
Accuracy of IOL power calculation can be significantly increased through the use of a low-coherence laser interferometry device (Lenstar LS900, Haag-Streit) for optical biometry combined with a last-generation, four-variable, "paraxial" ray-tracing formula (Olsen formula; PhacoOptics software, IOL Innovations). The benefit is due to improved prediction of postoperative IOL position, said Thomas Olsen, MD.
Medical retinal imaging company Optos plc has delivered its first next-generation ultra-widefield retinal imaging devices (Daytona) to customers. The new devices have been scaled to accommodate smaller office spaces while providing high-resolution imaging and adding new autofluorescence capabilities.
Sightpath Medical has launched a new Web site, www.SightpathMedical.com, designed to help ophthalmic professionals learn about the company's services and locate resources.
iCo Therapeutics and JDRF, formerly the Juvenile Diabetes Research Foundation, have joined forces in a phase II clinical trial to investigate the investigational drug iCo-007 as a treatment for diabetic macular edema (DME).
During Sports Eye Safety Month in April, the American Academy of Ophthalmology, through its EyeSmart program, is reminding athletes to wear appropriate, sport-specific protective eyewear, properly fitted by an eye-care professional, to prevent a sports-related eye injury.
Prevent Blindness America (PBA) has designated April as Women's Eye Health and Safety Month.
May 1 is the nomination deadline for the New York Academy of Medicine (NYAM) Lewis Rudin Glaucoma Prize.
Former Association for Research in Vision and Ophthalmology (ARVO) Executive Director Joanne G. Angle died March 8. She was 70 and had cancer.
Both systemic and localized treatment for vision-threatening uveitis are effective in improving visual acuity and controlling uveitis and macular edema, according to results from the Multicenter Uveitis Steroid Treatment (MUST) trial as presented by Jennifer E. Thorne, MD, PhD, here at the 24th annual Current Concepts in Ophthalmology meeting.
.png "Optometry Times"){kind=logo}
